These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31764386)

  • 1. Ethnic disparities in pain processing among healthy adults: μ-opioid receptor binding potential as a putative mechanism.
    Letzen JE; Mun CJ; Kuwabara H; Burton EF; Boring BL; Walls T; Speed TJ; Wong DF; Campbell CM
    Pain; 2020 Apr; 161(4):810-820. PubMed ID: 31764386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
    Nuechterlein EB; Ni L; Domino EF; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).
    Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ
    Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional brain [(11)C]carfentanil binding following tobacco smoking.
    Domino EF; Hirasawa-Fujita M; Ni L; Guthrie SK; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():100-104. PubMed ID: 25598501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.
    Schrepf A; Harper DE; Harte SE; Wang H; Ichesco E; Hampson JP; Zubieta JK; Clauw DJ; Harris RE
    Pain; 2016 Oct; 157(10):2217-2225. PubMed ID: 27420606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects.
    Campbell CM; Bounds SC; Kuwabara H; Edwards RR; Campbell JN; Haythornthwaite JA; Smith MT
    Pain Med; 2013 Dec; 14(12):1882-92. PubMed ID: 24102962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.
    Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK
    Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
    Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
    Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of the μ-opioid system to social rejection and acceptance.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Wang H; Ni L; Walker SJ; Mickey BJ; Korycinski ST; Koeppe RA; Crocker JK; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2013 Nov; 18(11):1211-7. PubMed ID: 23958960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of [
    Kelleher AC; Pearson TD; Ramsey J; Zhao W; O'Conor KA; Bakhoda A; Stodden T; Guo M; Eisenberg SM; Shah SV; Freaney ML; Kim W; Kang Y; Tomasi D; Johnson C; Fang CA; Volkow ND; Kim SW
    Sci Rep; 2024 Jul; 14(1):16250. PubMed ID: 39009645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
    Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
    Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute acetate administration increases endogenous opioid levels in the human brain: A [
    Ashok AH; Myers J; Frost G; Turton S; Gunn RN; Passchier J; Colasanti A; Marques TR; Nutt D; Lingford-Hughes A; Howes OD; Rabiner EA
    J Psychopharmacol; 2021 May; 35(5):606-610. PubMed ID: 33406950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.
    Kuwabara H; Heishman SJ; Brasic JR; Contoreggi C; Cascella N; Mackowick KM; Taylor R; Rousset O; Willis W; Huestis MA; Concheiro M; Wand G; Wong DF; Volkow ND
    PLoS One; 2014; 9(12):e113694. PubMed ID: 25493427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.
    Hagelberg N; Aalto S; Tuominen L; Pesonen U; Någren K; Hietala J; Scheinin H; Pertovaara A; Martikainen IK
    Neurosci Lett; 2012 Jul; 521(1):11-4. PubMed ID: 22622175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult attachment style is associated with cerebral μ-opioid receptor availability in humans.
    Nummenmaa L; Manninen S; Tuominen L; Hirvonen J; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Dunbar RI; Sams M
    Hum Brain Mapp; 2015 Sep; 36(9):3621-8. PubMed ID: 26046928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.
    Tuominen L; Nummenmaa L; Keltikangas-Järvinen L; Raitakari O; Hietala J
    Hum Brain Mapp; 2014 May; 35(5):1875-84. PubMed ID: 23671038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.